Introduction
Glycosylated hemoglobin (HbAj) has been correlated with prior blood glucose levels and has been in the pregnant and non-pregnant diabetics as a possible index of both long and short term glucose control [7] . Factors other than blood glucose concentration have been reported to alter the value of HbAj [2] . Hemoglobinopathy is one of these [1] . This paper reports the results of a prospective and retrospective evaluation of HbAj in patients with "normal" and 'Variant" hemoglobin.
Materials and Methods
This study was carried out at Sloane Hospital for Women of Columbia-Presbyterian Medical Center. The patients belonged to obstetric clinic population, which comprises of 49 percent hispanics, 44 percent blacks, and 7 percent others. Earlier, the pregnant patients at high risk for diabetes were screened using plasma sugars (fasting and 2 hours post 100 gms oral glucose-load) and HbAj as screening parameters. The mean HbAj in patients with normal plasma sugars was 6.17 ± 0.6. Seventeen patients with HbAj value of 5 or less (2 S.D. below mean) were identified as study-groupexperimental group. Another group of 17 patients, randomly selected and matched according to age, parity, gestational age and hematocrit with the first group; and HbA x above 5 gms. percent were selected as a control group. HbA 1 was also measured in a third group of six patients with known hemoglobinopathy. The patients in first two groups were investigated for the presence of hemoglobinopathy by careful review of their medical records, sickle cell solubility test or hemoglobin electrophoresis. Hemoglobin A t determinations were performed by cation exchange column chromatography, using micro-column fast-hemoglobin test system (ISOLAB, Akron, Ohio). Columns and reagents were equilibrated at 22 °C-24 °C before performing and during the test. Blood specimens were collected in heparinized tubes. Specimens were tested, when freshly drawn. When this was not possible, a hemolysate was prepared and stored at 4°C. All specimens were analysed within 48 hours. The distribution of the data was evaluated by ordered Chi square analysis and relative risk assessment.
Results
Of seventeen control patients with HbAi greater than 5 percent, 15 had HbAA or negative sickle cell solubility test and two had sickle cell trait. Of seventeen patients with HbA 1 less than 5 percent, 14 had sickle cell trait and two had C trait. The remaining patient had a negative sickle cell solubility test. The distribution of these cases is shown in Tab [3] . Glycosylation of the N-terminal amino acid of the beta chain of HbA changes its mobility in cation exchange chromatography allowing separation from the parent hemoglobin molecule [3] .
Other types of hemoglobin, (such as hemoglobin S, F or C), also have differing mobilities on cation exchange column chromatography. Hemoglobin F happens to elute in the same fraction as HbA l5 whereas hemoglobin S and hemoglobin C elute in different fractions [1, 7] . It has been shown that glycosylation occurs in other parts of both the alpha and beta chains of hemoglobin A, and presumably of other hemoglobins [5] . Only glycosylation of the N-terminal valine of the beta chain significantly changes its Chromatographie mobility [5] . Although the alpha, beta and beta S subunits of a patient with sickle cell trait may be glycosylated, only hemoglobin with a glycosylated beta subunit will be measured in the HbAj fraction. The presence of total glycosylated hemoglobin in such a patient may, thus, be underestimated. This phenomenon has been previously reported in non-pregnant patient [6] . The significant difference in HbAj as measured by column chromatography between subjects with "normal" hemoglobin and those with hemoglobin AS and hemoglobin AC represents a difference in the presence of glycosylated beta chains rather than glycosylation per se. Perhaps, for the same reason, the patient with hemoglobin SC disease had a very low percentage of HbA! (Tab. II, not included in Tab. I).
In patients with thalassemia minor, there is a compensatory increase in fetal hemoglobin to make up for the defect in beta chain synthesis. There may be no increase in glycosylation. However, since the Chromatographie mobility of fetal hemoglobin and HbAj arc similar, the percentage of HbAj^ in these patients may be overestimated [7] . is a valuable indicator of the integrated plasma glucose level over the previous 4 to 6 weeks, and therefore, a useful adjunct in the management of diabetic pregnancy [3] . The estimation of HbAj by cation exchange column chromatography enables one to identify patients with variant hemoglobins. However, obtaining a single value interferes with the assessment of diabetes in the patients with hemoglobinopathy. These technical problems could be overcome if the colorimetric method was used in the estimation of glycosylated hemoglobins.
Summary
Glycosylated hemoglobin (HbAj) is considered to be representative of prior blood-glucose levels and is being used in pregnant and nonpregnant diabetic patients as a possible index of both long and short-term glucosecontrol. Factors other than blood-glucose concentration have been reported to affect its value. Variant hemoglobin is one of them. HbA^ and blood-glucose levels were measured in pregnant patients at high risk for diabetes for screening for abnormal carbohydrate metabolism. HbAj was measured by cation exchange column chromatography and glucose was measured by hexokinase reaction. The mean HbAj in patients with normal blood sugars Keywords: Glycosylatin, hemoglobin, hemoglobinopathy was 6.17 ±0.6 percent. A value of HbAj of less than 5 percent as measured by cation exchange column chromatography was highly predictive (P < 0.001) of hemoglobinopathies (S or C). The mean HbAj of randomly selected matched patients with "normal" Mb was 5.94 ± 0.72 percent. In patients with thalassemia, HbAj values as measured by cation exchange column chromatography were elevated despite normal carbohydrate tolerance. While interpreting the results of HbAj in the management of pregnant diabetics, the above fact should be kept in mind. Mots-cles: Glycosylation, hemoglobine, hemoglobinopathie.
